News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
High levels of fertility-related hormone linked to increased breast cancer risk, new study finds
Having high levels of anti-Müllerian hormone (AMH) – a hormone that indicates the size of a woman’s ovarian reserve – before the menopause is associated with an increased risk of breast cancer, research suggests.
Scientists dig up cancer’s secrets buried in ‘gene deserts’
Scientists have found a way to uncover the secrets behind the development of cancer hidden away amongst vast ‘gene deserts’ in our DNA.
Genetic testing could pick out people at three-fold increased risk of bone marrow cancer
Assessing DNA for areas of the genome linked to cancer risk could pick out some people with a three-fold increased risk of blood cancer, a new study suggests.
Viruses show new promise in treating cancer
Viruses have shown renewed promise in the treatment for cancer, after new research has shown they retain their cancer-killing ability even when injected into the bloodstream.
ICR supporters launch exciting new cycling challenge – Ride of Life
Top researchers waved off a group of our most dedicated supporters as they embarked on a new cycling challenge, which has already raised over £12,500 for the ICR.
Immunotherapy could offer hope for some men with aggressive prostate cancers
A group of men with especially aggressive prostate cancer may respond unusually well to immunotherapy, a major new study reports.
Artificial intelligence can predict how cancers will evolve and spread
Scientists have used artificial intelligence to predict how cancers will progress and evolve – so that doctors can design the most effective treatment for each patient.
Genetic ‘weather forecasting’ could predict bowel cancer’s response to treatment
Blood tests could predict how long it takes until bowel cancer returns based on the same principle used in forecasting the weather, a new study has found.
ICR responds to NICE decision about CAR T immunotherapy for non-Hodgkin lymphoma
The ICR responds to draft decision not to recommend CAR T cell therapy for two types of non-Hodgkin lymphoma.
ICR statement on allegations of bullying
The Institute of Cancer Research, London, is making the following statement regarding an investigation we have conducted into allegations of bullying by a staff member.
New computer prediction tool can forecast how cancer will resist drugs before they are given to patients
Sophisticated new computer software can be used to predict how cancers may respond to a new drug before it has ever been given to patients.
Drug combination gives ‘exciting’ results in ovarian and lung cancer in early trial
Combining a new targeted cancer drug with chemotherapy has shown promise in an early clinical trial, in patients with ovarian or lung cancer for whom all other treatments had failed.
